Poststroke Depression Biomarkers: A Narrative Review
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Poststroke depression (PSD) is the most prevalent psychiatric disorder after stroke, which is independently correlated with negative clinical outcome. The identification of specific biomarkers could help to increase the sensitivity of PSD diagnosis and elucidate its pathophysiological mechanisms. The aim of current study was to review and summarize literature exploring potential biomarkers for PSD diagnosis. The PubMed database was searched for papers published in English from October 1977 to December 2017, 90 of which met inclusion criteria for clinical studies related to PSD biomarkers. PSD biomarkers were subdivided into neuroimaging, molecular, and neurophysiological. Some of them could be recommended to support PSD diagnosing. According to the data, lesions affecting the frontal-subcortical circles of mood regulation (prefrontal cortex, basal nuclei, and thalamus) predominantly in the left hemisphere can be considered as neuroimaging markers and predictors for PSD for at least 1 year after stroke. Additional pontine and lobar cerebral microbleeds in acute stroke patients, as well as severe microvascular lesions of the brain, increase the likelihood of PSD. The following molecular candidates can help to differentiate PSD patients from non-depressed stroke subjects: decreased serum BDNF concentrations; increased early markers of inflammation (high-sensitivity C-reactive protein, ferritin, neopterin, and glutamate), serum pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-18, IFN-γ), as well as pro-inflammatory/anti-inflammatory ratios (TNF-α/IL-10, IL-1β/IL-10, IL-6/IL-10, IL-18/IL-10, IFN-γ/IL-10); lowered complement expression; decreased serum vitamin D levels; hypercortisolemia and blunted cortisol awakening response; S/S 5-HTTLPR, STin2 9/12, and 12/12 genotypes of the serotonin transporter gene SLC6A4, 5-HTR2a 1438 A/A, and BDNF met/met genotypes; higher SLC6A4 promoter and BDNF promoter methylation status. Neurophysiological markers of PSD, that reflect a violation of perception and cognitive processing, are the elongation of the latency of N200, P300, and N400, as well as the decrease in the P300 and N400 amplitude of the event-related potentials. The selected panel of biomarkers may be useful for paraclinical underpinning of PSD diagnosis, clarifying various aspects of its multifactorial pathogenesis, optimizing therapeutic interventions, and assessing treatment effectiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Differential impact of lacunes and microvascular lesions on poststroke depression
Santos, M., Gold, G., Kövari, E., Herrmann, F. R., Bozikas, V. P., Bouras, C., & Giannakopoulos, P. (2009) · Stroke · doi:10.1161/strokeaha.109.548545 · Cited by 91 · cited 1×
“Nevertheless, accumulation of subcortical lacunar lesions in the deep white matter, basal ganglia, and thalamus might be a more significant predictor of PSD than solitary lacunas (51, 52).”
BackgroundPossible contribution of IGF-1 to depressive disorder
Szczęsny, E., Ślusarczyk, J., Głombik, K., Budziszewska, B., Kubera, M., Lasoń, W., & Basta-Kaim, A. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71523-8 · Cited by 68 · cited 3×
“Most of the studies showed that increased peripheral IGF-1 levels might predict the occurrence of MDD, whereas decreased IGF-1 levels might reflect the treatment effectiveness (96).”
BackgroundLee, J. Y., Lim, O. K., Lee, J. K., Park, Y., Kim, C., Yoon, J. W., & Park, K. D. (2015) · Annals of Rehabilitation Medicine · doi:10.5535/arm.2015.39.5.786 · Cited by 17 · cited 1×
“(78) Case-control PSD Non-PSD 60 70 DSM-IV, BDI Higher serum leptin levels were found in PSD group compared to non-PSD (38.”
Cited by
Post-stroke depression: A 2020 updated review
Medeiros, G. C., Roy, D., Kontos, N., & Beach, S. R. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.06.011 · Cited by 587
Effect of Inflammation on the Process of Stroke Rehabilitation and Poststroke Depression
Fang, M., Zhong, L., Jin, X., Cui, R., Yang, W., Gao, S., Lv, J., Li, B., & Liu, T. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00184 · Cited by 66
Interleukin-10 Level Is Associated with Post-Stroke Depression in Acute Ischaemic Stroke Patients
Chi, C.-H., Huang, Y.-Y., Ye, S.-Z., Shao, M.-M., Jiang, M.-X., Yang, M.-Y., Wu, Q., Shao, B., & Li, X.-M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.06.037 · Cited by 50
Serum Interferon-Gamma Level Is Associated with Drug-Naïve Major Depressive Disorder
Daria, S., Proma, M. A., Shahriar, M., Islam, S. M. A., Bhuiyan, M. A., & Islam, M. R. (2020) · SAGE Open Medicine · doi:10.1177/2050312120974169 · Cited by 46
Elevated monocyte-to-HDL cholesterol ratio predicts post-stroke depression
Li, Y., Zhang, M., Xue, M., Liu, D., & Sun, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.902022 · Cited by 27
Metadata
- Authors
- Levada, O. A., & Troyan, A. S.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2018-07-16
- Volume
- 9
- Pages
- 577-577
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W2884315787
- Cited by
- 89
- References
- 3
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.